You are here:

MS in the media - 12 May 2017

Published on

6 - 12 May 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Statins for SPMS

The next phase of research into statins in secondary progressive MS has been announced. The six year trial will start recruiting in the summer and will involve 1,180 people taking either simvastatin or a placebo at 30 hospitals across the UK.

Source: Daily Telegraph
Source: Guardian
Source: Daily Mail

MS Trust link: Simvastatin trial planned for secondary progressive multiple sclerosis (MS Trust news story - includes link to register interest in taking part in the trial)

Laquinimod trial unsuccessful

A phase III trial looking at whether laquinimod was better than placebo at slowing the time to confirmed disability progression in people with relapsing remitting MS has failed to show any difference.  A trial in primary progressive MS continues.

Source: Teva press release
Source: MS News Today

MS Trust link: Laquinimod

Clues to MS five years before onset

Canadian research looking at health records from 1984-2014 found that people who developed MS made more use of health care than the general population in the five years before their first symptoms appeared.

Source: Specialty Pharmacy Times

MS Trust link: Early signs of MS

Vitamin D and birth month

Polish research found that while there were fewer cases of MS in the autumn compared to the spring, this didn't seem to correlate with a pregnant mother's exposure to sunlight. Previous studies have linked the pattern of birth months with the mother's vitamin D levels during pregnancy

Source: MS News Today

MS Trust link: Vitamin D

Contraceptive safety in MS

A study found oral contraceptives weren't linked to risk of relapses in women with MS. A separate report says most contraceptive methods appear safe for women with MS based on current evidence (the exception being hormonal contraceptives in women with prolonged immobility).

Source: National MS Society (USA)

MS Trust link: Contraception

Carers and the impact of MS

Discussion of the role of carers, their perspective on the person with MS they care for and tips to avoid burn out

Source: MS News Today

MS Trust link: Carers

Print this page